Publication of Cancellation of Entries for Kinds of Medical Devices from the Australian Register of Therapeutic Goods - Hendricks Instruments Service Pty Ltd - 163380

Overview

The Therapeutic Goods Act 1989 was enacted to provide for the regulation of therapeutic goods in Australia, ensuring that the public has access to safe, quality and effective therapeutic goods. The Act was introduced to address the need for a comprehensive legislative framework that governs the manufacturing, importation, advertising, supply, and exportation of therapeutic goods, including medicines, medical devices, blood, and tissues. The Therapeutic Goods Administration (TGA), as the executive arm of the Commonwealth Government responsible for regulating therapeutic goods, operates under the authority of the Department of Health and Ageing. The policy objective of the Act is to protect public health by minimising the risks associated with the use of therapeutic goods, while facilitating timely access to therapeutic goods of acceptable quality, safety, and efficacy. This particular legislative instrument, Gazetted as C2013G01209, pertains to the cancellation of entries for kinds of medical devices from the Australian Register of Therapeutic Goods. The cancellation is due to issues such as incorrect classification, non-compliance with essential principles, and failure to provide evidence of conformity assessment procedures. The decision to cancel the entry was made by Rodolfo Ferrari, a delegate of the Secretary to the Department of Health and Ageing, and was published in accordance with section 41GP of the Therapeutic Goods Act 1989. The cancellation took effect on 30 September 2013.

Scope and Application

The Therapeutic Goods Act 1989 applies to a broad range of therapeutic goods, including medical devices, in Australia, with the Therapeutic Goods Administration (TGA) under the Department of Health and Ageing overseeing its implementation. The Act is applicable to persons and entities involved in the supply, advertising, and representation of therapeutic goods within Australia, ensuring that these goods meet safety, quality, and efficacy standards. The jurisdictional reach of the Act is national, governing the entire Commonwealth of Australia. The Act's provisions can be extended or further specified through subordinate instruments such as regulations and guidelines, which provide additional detail on particular types of goods or specific circumstances. Notably, the Act does not apply to goods that are exempt under specific sections, such as goods used for personal, non-commercial purposes or those that fall under state jurisdiction. The specific notice of the cancellation of an entry for a kind of medical device from the Australian Register of Therapeutic Goods (ARTG) is a demonstration of the Act’s application to medical devices. In this instance, the cancellation pertains to endotherapy forceps with the ARTG number 163380, manufactured by Reda Instrument GmbH and sponsored by Hendricks Instruments Service Pty Ltd. The cancellation was due to several non-compliance issues, including incorrect classification, failure to provide necessary sponsor details, non-compliant information supplied with the device, and failure to provide evidence of conformity assessment procedures. This cancellation reflects the stringent measures in place to ensure that therapeutic goods available in Australia meet the necessary regulatory standards.

Key Provisions

The Therapeutic Goods Act 1989 (the Act) mandates that the Therapeutic Goods Administration (TGA) must publish details regarding the cancellation of certain entries from the Australian Register of Therapeutic Goods (ARTG). In this instance, section 41GP of the Act (subsections 41GN(1)(b) and (f)) requires the publication of the cancellation of an ARTG entry for a specific kind of medical device. The device in question is an endotherapy forceps with the ARTG number 163380, sponsored by Hendricks Instruments Service Pty Ltd and manufactured by Reda Instrument GmbH (Germany). The cancellation decision was made on 2 August 2013 and took effect on 30 September 2013. Under the Act, parties such as sponsors and manufacturers have certain obligations. For medical devices, sponsors must ensure that their details are included in the device information, and manufacturers must comply with the essential principles outlined in the Regulations. They must also correctly classify the device and provide evidence that conformity assessment procedures have been applied. Failure to meet these obligations can lead to the cancellation of the ARTG entry. Breaching the requirements set forth in the Act can result in significant consequences. The Act specifies that incorrect certification of a device under sections 41FD(c), 41FD(d), and 41FD(f) is a ground for cancellation of an ARTG entry. In this particular case, the endotherapy forceps were incorrectly classified, did not have sponsor details in the device information, and failed to comply with the essential principles. Additionally, there was a failure to provide evidence that conformity assessment procedures had been applied. The cancellation of the ARTG entry serves as a formal notice that the device is no longer approved for the Australian market. There are no specified maximum penalties mentioned in the Act for the cancellation of an ARTG entry, but the consequences can be severe. The cancellation effectively removes the device from the Australian market, prohibiting its sale, supply, and representation as a therapeutic good. Companies may face reputational damage, loss of market access, and potential legal action if they continue to market the non-compliant device after the cancellation.